Healthcare -
Biotechnology - NASDAQ - US
$ 110.05
5.87 %
$ 6.99 B
Market Cap
-52.66
P/E
BPMC - COST OF REVENUE
Cost of Revenue BPMC - Blueprint Medicines Corporation
12.8 M
LAST VALUE
-15.53%
2 YEAR CAGR
-44.53%
5 YEAR CAGR
-2.17%
10 YEAR CAGR